Products search
News search
Search ...
Search
About Us
Our History
Our Values, Mission & Vision
Domestic Distribution
Privacy Policy
News
Activities
Products
Analgesic - Antipyretic
Respiratory
Nutrition
Musculoskeletal
Gastrointestinal – Hepatobiliary
Nervous – Ophthalmic
Cardiovascular – Diabetic
Dermatology – Beauty care
Overview
Export
Investor Relations
Announcement
2024
2023
2022
2021
2020
Read more
2019
2018
2017
2016
2015
2014
2013
Annual General Meeting (AGM)
2024
2023
2022
2021
2020
Read more
2019
2018
2017
2016
2015
2014
2013
Before 2012
Annual Report
Financial Statements
2024
2023
2022
2021
2020
2019
2018
Read more
2017
2016
2015
2014
2013
Before 2012
IR News
DHG Pharma’s Charter
Regulation on Corporate Governance
Report on corporate governance
2024
2023
2022
2021
2020
Read more
2019
2018
2017
2015
Regulations on corporate governance
Contact
Home
Investor Relations
Financial Statements
2023
DHG Pharma Reviewed Financial Statements 1H/2023
DHG Pharma Reviewed Financial Statements 1H/2023
Details
Published: 14 August 2023
Hits: 33837
f
Share
Tweet
+
Reviewed Financial Statements 1H/2023
+
Explanation of reviewed financial statements
1H/2023
Newer news items:
Audited Financial Statements in 2023 -
08/03/2024 06:07
DHG Pharma Financial Statements in Q4/2023 -
19/01/2024 08:47
DHG Pharma Financial Statements Q3/2023 -
20/10/2023 08:17
Older news items:
Financial statements in Q2/2023 -
20/07/2023 08:37
Financial statements in Q1/2023 -
20/04/2023 08:52